Total Payments
$2,734
2024 Payments
$449.51
Companies
33
Transactions
152
Medicare Patients
1,198
Medicare Billing
$121,845
Payment Breakdown by Category
Food & Beverage$2,664 (97.4%)
Education$70.44 (2.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,664 | 148 | 97.4% |
| Education | $70.44 | 4 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $413.62 | 22 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $237.44 | 16 | $0 (2019) |
| PFIZER INC. | $223.14 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $202.68 | 10 | $0 (2023) |
| Lilly USA, LLC | $193.74 | 10 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $191.31 | 12 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $137.74 | 5 | $0 (2019) |
| Kowa Pharmaceuticals America, Inc. | $110.50 | 5 | $0 (2020) |
| TherapeuticsMD, Inc. | $93.52 | 5 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $91.75 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $449.51 | 25 | ABBVIE INC. ($322.38) |
| 2023 | $202.25 | 9 | AbbVie Inc. ($78.37) |
| 2022 | $65.52 | 3 | GlaxoSmithKline, LLC. ($52.65) |
| 2021 | $83.46 | 5 | PFIZER INC. ($55.26) |
| 2020 | $191.13 | 10 | Lilly USA, LLC ($56.78) |
| 2019 | $631.46 | 32 | TherapeuticsMD, Inc. ($93.52) |
| 2018 | $580.76 | 34 | Takeda Pharmaceuticals U.S.A., Inc. ($151.40) |
| 2017 | $530.02 | 34 | Merck Sharp & Dohme Corporation ($95.92) |
All Payment Transactions
152 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $6.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Oncology | ||||||
| 08/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: NEUROSCIENCE | ||||||
| 08/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Biological | ||||||
| 08/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Diabetes | ||||||
| 05/09/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: VACCINES | ||||||
| 04/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/09/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: NEUROSCIENCE | ||||||
| 03/28/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: NEUROSCIENCE | ||||||
| 03/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $29.34 | General |
| Category: NEUROSCIENCE | ||||||
| 02/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 290 | 355 | $76,062 | $31,145 |
| 2022 | 6 | 272 | 355 | $58,851 | $29,239 |
| 2021 | 7 | 337 | 450 | $74,462 | $34,867 |
| 2020 | 7 | 299 | 403 | $83,879 | $26,594 |
Total Patients
1,198
Total Services
1,563
Medicare Billing
$121,845
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 60 | 60 | $19,260 | $9,354 | 48.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 71 | 112 | $24,864 | $7,582 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 63 | $19,719 | $6,828 | 34.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 35 | 35 | $4,585 | $2,518 | 54.9% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 18 | 18 | $4,281 | $2,313 | 54.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 38 | 38 | $1,558 | $1,404 | 90.1% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 18 | 18 | $1,278 | $886.86 | 69.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $517.00 | $259.05 | 50.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 61 | 61 | $15,291 | $9,230 | 60.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 70 | 123 | $20,929 | $8,483 | 40.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 75 | $14,796 | $6,665 | 45.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 41 | 41 | $5,371 | $2,810 | 52.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 43 | 43 | $1,763 | $1,601 | 90.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 12 | $701.00 | $450.94 | 64.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 112 | 188 | $31,264 | $12,374 | 39.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 97 | $23,207 | $9,735 | 41.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 57 | 57 | $13,328 | $8,583 | 64.4% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 40 | 40 | $2,800 | $2,610 | 93.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 39 | 39 | $1,554 | $842.79 | 54.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 11 | 14 | $2,024 | $670.38 | 33.1% |
| 81002 | Urinalysis, manual test | Office | 2021 | 15 | 15 | $285.00 | $52.20 | 18.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 131 | 208 | $45,552 | $12,909 | 28.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 59 | 81 | $26,001 | $7,802 | 30.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 19 | 19 | $6,669 | $2,666 | 40.0% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 30 | 31 | $2,170 | $1,890 | 87.1% |
About Dr. Tiffany Davies, M.D
Dr. Tiffany Davies, M.D is a Family Medicine healthcare provider based in Los Gatos, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386754133.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tiffany Davies, M.D has received a total of $2,734 in payments from pharmaceutical and medical device companies, with $449.51 received in 2024. These payments were reported across 152 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($2,664).
As a Medicare-enrolled provider, Davies has provided services to 1,198 Medicare beneficiaries, totaling 1,563 services with total Medicare billing of $121,845. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Los Gatos, CA
- Active Since 08/30/2006
- Last Updated 12/07/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386754133
Products in Payments
- Trintellix (Drug) $310.44
- QULIPTA (Drug) $297.57
- SHINGRIX (Biological) $128.99
- UBRELVY (Drug) $119.16
- EMGALITY (Drug) $111.97
- Livalo (Drug) $110.50
- AJOVY (Drug) $88.32
- IMVEXXY (Drug) $75.00
- INVOKANA (Drug) $71.39
- JANUVIA (Drug) $70.98
- EUCRISA (Drug) $62.91
- VRAYLAR (Drug) $60.48
- INTRAROSA (Drug) $55.84
- QVAR (Drug) $49.42
- TRULICITY (Drug) $46.95
- ASMANEX (Drug) $46.15
- Trulance (Drug) $43.13
- COLOGUARD DNA CAPTURE REAGENTS (Device) $40.60
- COMIRNATY (Biological) $38.56
- VYVANSE (Drug) $38.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Los Gatos
Jennifer Haggerty, M.d, M.D
Family Medicine — Payments: $6,952
Family Medicine $6,952
Rodney Gin, M.d, M.D
Family Medicine — Payments: $6,901
Family Medicine $6,901
Dr. J Zimmer, Md, MD
Family Medicine — Payments: $5,030
Family Medicine $5,030
Dr. Mary Defigard, Md, MD
Family Medicine — Payments: $4,173
Family Medicine $4,173
Dr. Kathryn Shade, M.d, M.D
Family Medicine — Payments: $2,886
Family Medicine $2,886
Dr. Norman Chow, D.o, D.O
Family Medicine — Payments: $2,790
Family Medicine $2,790